The quality statements for the Heavy Menstrual Bleeding Clinical Care Standard are based on best available evidence and guideline recommendations at the time of development. This summary describes the relevance of each evidence source to the quality statements.
A Topic Working Group was convened to provide advice to the Commission on this project. The group comprised individuals with relevant expertise in delirium, representatives of key stakeholder organisations as well as a consumer representative.
A Topic Working Group has been convened to provide advice to the Commission on this standard. The group is comprised of individuals with relevant expertise and clinical experience as well as consumer representatives.
The public consultation period took place from 18 December 2013 to 14 March 2014. A total of 80 responses were received by the Commission as part of this consultation process.